Help - Search - Members - Calendar
Full Version: Asbestosis
Online Medical Forum > Library Database Of Journals Publications Researches Category > Library Database Of Journals Publications Researches > Medicine Category > Internal Medicine Forum > Medicine Topics > Asbestosis
Pages: 1, 2, 3, 4, 5, 6
  1. Man with mesothelioma refuses autopsy in asbestos-related lawsuit (0 replies)
  2. Creditors raise objections to w.r. grace bankruptcy reorganization plan (0 replies)
  3. State and county decline to handle asbestos risk in cantonville, maryland (0 replies)
  4. Mesothelioma victims getting support from politicians (0 replies)
  5. Three possible health dangers of long-term cell phone use (0 replies)
  6. Malignant mesothelioma of the tunica vaginalis of the testis without exposure to asbestos: a case report (0 replies)
  7. Asbestos problems persist at colorado university campus (0 replies)
  8. New mesothelioma incidence rate study shows decline in cases (0 replies)
  9. Cancer fears (0 replies)
  10. Uganda: 'jinja hospital in sorry state' (0 replies)
  11. Asbestos-related pleural and lung fibrosis in patients with retroperitoneal fibrosis (0 replies)
  12. Epa takes regulatory action against nanotechnology (0 replies)
  13. Asbestos is a concern at milford, new jersey paper mill (0 replies)
  14. Mesothelioma risk for residents near abandoned asbestos mine (0 replies)
  15. Factors influencing the prevalence of pulmonary nodules in lung cancer screening trials: re-evaluation of a ct study. (0 replies)
  16. Fear of mesothelioma forces an investigation on illinois epa headquarters (0 replies)
  17. Mesothelioma and asbestos-related lawsuits show tragedy of asbestos exposure (0 replies)
  18. Occupational exposure to asbestos and man-made vitreous fibers, and risk of lung cancer: evidence from two case-control studies in montreal, canada. (0 replies)
  19. Pathways affected by asbestos exposure in normal and tumour tissue of lung cancer patients (0 replies)
  20. Pleomorphic carcinoma of the lung expressing podoplanin and calretinin (0 replies)
  21. Asbestos liability forces christy refractories into bankruptcy (0 replies)
  22. Mesothelioma and secondary asbestos exposure verdict awards florida couple $3.6 million (0 replies)
  23. Mesothelioma diagnosis urges man to file lawsuit (0 replies)
  24. Outcomes with first-line platinum-based combination chemotherapy for malignant pleural mesothelioma: a review of practice in british columbia. (0 replies)
  25. Insurers to challenge new asbestos law (0 replies)
  26. Novel and existing mutations in the tyrosine kinase domain of the epidermal growth factor receptor are predictors of optimal resectability in malignant peritoneal mesothelioma (0 replies)
  27. Mesothelioma causing asbestos fails to make watch list as pesticide does (0 replies)
  28. Homeowners seeking justice after contractor ruined homes (0 replies)
  29. Beware of asbestos workers with false certification (0 replies)
  30. Why study asbestos? (0 replies)
  31. [original articles] preoperative staging of mesothelioma by 18f-fluoro-2-deoxy-d-glucose positron emission tomography/computed tomography fused imaging and mediastinoscopy compared to pathological findings after extrapleural pneumonectomy (0 replies)
  32. Inquiry into cost of asbestos pay-outs (0 replies)
  33. Mesothelioma patients don’t receive enough support (0 replies)
  34. Use of nanoparticles in cosmetics questioned (0 replies)
  35. Etuc presents concerns over asbestos decision at rotterdam conference (0 replies)
  36. Mesothelioma and asbestos lawsuits filed in texas (0 replies)
  37. Mesothelioma and other asbestos-related diseases a big concern after recent asbestos report (0 replies)
  38. Epidemiology of kidney cancer (0 replies)
  39. Mesothelioma-related lawsuit filed by michigan couple (0 replies)
  40. Mesothelioma lawsuit filed on behalf of past navy worker (0 replies)
  41. Clinical consequences of asbestos-related diffuse pleural thickening: a review (0 replies)
  42. Characteristics and modifying factors of asbestos-induced oxidative dna damage (0 replies)
  43. Prevention of malignant seeding at drain sites after invasive procedures (surgery and/or thoracoscopy) by hypofractionated radiotherapy in patients with pleural mesothelioma. (0 replies)
  44. Systemic treatments for mesothelioma: standard and novel (0 replies)
  45. Asbestos-related condition 'a good thing', says lawyer (0 replies)
  46. Protein kinase c beta in malignant pleural mesothelioma. (0 replies)
  47. Asbestos damages plans 'flawed' (0 replies)
  48. Asbestos damages plans 'flawed' (0 replies)
  49. Malignant pleural mesothelioma-targeted crebbp/ep300 inhibitory protein 1 promoter system for gene therapy and virotherapy. (0 replies)
  50. Britain's youngest asbestos victim dies at 28: did she contract it at school? (0 replies)
  51. Britain's youngest asbestos victim dies at 28: did she contract it at school? (0 replies)
  52. Airborne environmental exposure to asbestos. (0 replies)
  53. Diagnosis, staging,
    and surgical treatment of malignant pleural mesothelioma     (0 replies)
  54. Recent advances in the treatment of malignant pleural mesothelioma. (0 replies)
  55. [original articles] development of a fibre size-specific job-exposure matrix for airborne asbestos fibres (0 replies)
  56. [original articles] an epidemiological study of the role of chrysotile asbestos fibre dimensions in determining respiratory disease risk in exposed workers (0 replies)
  57. Malignant pleural mesothelioma-targeted crebbp/ep300 inhibitory protein 1 promoter system for gene therapy and virotherapy (0 replies)
  58. Asbestos-related diseases: time for technology sharing (0 replies)
  59. Optical detection and grading of lung neoplasia by raman microspectroscopy (0 replies)
  60. Asbestos clinics and asbestos health examinations -findings from a questionnaire survey ofimplementing organizations. (0 replies)
  61. Successful palliation of malignant ascites from peritoneal mesothelioma by laparoscopic intraperitoneal hyperthermic chemotherapy. (0 replies)
  62. Evaluation of public and worker exposure due to naturally occurring asbestos in gravel discovered during a road construction project (0 replies)
  63. Targeting alpha7-nicotinic receptor for the treatment of pleural mesothelioma. (0 replies)
  64. Cancer sufferer awarded £130,000 in asbestos case (0 replies)
  65. Occupational exposure to asbestos and mortality among asbestos removal workers: a poisson regression analysis (0 replies)
  66. The microbial and danger signals that activate nod-like receptors. (0 replies)
  67. Mesothelioma epidemiology, carcinogenesis, and pathogenesis (0 replies)
  68. Hospital-acquired infections preventable, to prompt 'next wave' of class-action lawsuits, opinion piece states (0 replies)
  69. Recent mortality from pleural mesothelioma, historical patterns of asbestos use and adoption of bans: a global assessment (0 replies)
  70. Asbestos exposure predicts cell cycle control gene promoter methylation in pleural mesothelioma (0 replies)
  71. Recent mortality from pleural mesothelioma, historical patterns of asbestos use and adoption of bans: a global assessment (0 replies)
  72. National mesothelioma virtual bank: a standard based biospecimen and clinical data resource to enhance translational research (0 replies)
  73. City may sue over asbestos abatement issues (0 replies)
  74. Montpelier schools will open late due to asbestos problems (0 replies)
  75. Piezodriven 50-mu m range stage with subnanometer resolution (0 replies)
  76. New asbestos lawsuit filed in madison county, illinois (0 replies)
  77. Epa and east liverpool finally reach an agreement on asbestos fine (0 replies)
  78. Hse prosecutes essex companies following multiple breaches of asbestos safety laws, uk (0 replies)
  79. Mesothelioma (0 replies)
  80. Retraction: pathogenesis of malignant pleural mesothelioma and the role of environmental and genetic factors (0 replies)
  81. Delaware school fined for asbestos violations (0 replies)
  82. Asbestos problems for more schools in montpelier, vermont (0 replies)
  83. Novel functional view of the crocidolite asbestos-treated a549 human lung epithelial transcriptome reveals an intricate network of pathways with opposing functions (0 replies)
  84. Epa to fund new brownfields project in sc (0 replies)
  85. Epa superfund work upsets ambler residents (0 replies)
  86. Cincinnati foundry fined by osha for safety and health violations (0 replies)
  87. Asbestos fibre concentrations in the lungs of brake workers: another look (0 replies)
  88. Exposure to chrysotile asbestos associated with unpacking and repacking boxes of automobile brake pads and shoes (0 replies)
  89. Epa monitoring air quality during iowa flood clean-up (0 replies)
  90. The serine protease htra1 is a novel prognostic factor for human mesothelioma (0 replies)
  91. Targeted therapy in malignant mesothelioma (0 replies)
  92. Montpelier school clean-up will cost $50,000 (0 replies)
  93. Aspen school district has ongoing asbestos problems (0 replies)
  94. Two new asbestos lawsuits filed in west virginia (0 replies)
  95. Some 9/11 first responders are still waiting for medical treatment (0 replies)
  96. Federal epa gets involved in asbestos issues at montpelier school (0 replies)
  97. Dupont denied writ of mandamus in whisnant case (0 replies)
  98. Asbestos may keep vermont school closed into the new school year (0 replies)
  99. Comparison of osteopontin, megakaryocyte potentiating factor, and mesothelin proteins as markers in the serum of patients with malignant mesothelioma. (0 replies)
  100. That asbestos season. (0 replies)
  101. 2008 international mesothelioma symposium provides support and education (0 replies)
  102. Parents of thomas o’brien academy students learn of asbestos problems at school (0 replies)
  103. Book review: asbestos and its diseases (0 replies)
  104. Investigating 'community' through a history of responses to asbestos-related disease in an australian industrial region (0 replies)
  105. Establishment of a human malignant fibrous mesothelioma cell line and the biological characteristics compared with malignant epithelial mesothelioma cell line (0 replies)
  106. An evaluation of short-term exposures of brake mechanics to asbestos during automotive and truck brake cleaning and machining activities (0 replies)
  107. New asbestos lawsuit filed by colorado woman (0 replies)
  108. [institutional report - thoracic general] the role of muscle flap in preventing bronchus stump insufficiency after pneumonectomy for malignant pleural mesothelioma in high-risk patients (0 replies)
  109. Met as a target for treatment of chest tumors. (0 replies)
  110. Clear cell sarcoma mimicking malignant pleural mesothelioma. (0 replies)
  111. Pa health department says borit site is not hazardous to the public (0 replies)
  112. More criticism for epa’s asbestos regulations plans (0 replies)
  113. Grants help philadelphia school remove dangerous asbestos (0 replies)
  114. W.r. grace bankruptcy court sets bar date for zonolite claims (0 replies)
  115. Nj man files asbestos lawsuit in il (0 replies)
  116. Could vitamin d help people with mesothelioma? (0 replies)
  117. Tempe union school district will retest all schools for asbestos (0 replies)
  118. Four new asbestos lawsuits filed in west virginia (0 replies)
  119. Veterans with asbestos-related breathing diseases may be entitled to compensation from the federal government, canada (0 replies)
  120. Pathogenesis of malignant pleural mesothelioma and the role of environmental and genetic factors (0 replies)
  121. Two new asbestos suits filed in west virginia (0 replies)
  122. Ala report finds deaths from lung disease increasing (0 replies)
  123. A pharmacologic analysis of intraoperative intracavitary cancer chemotherapy with doxorubicin (0 replies)
  124. Former pipe-fitter files second asbestos-related lawsuit (0 replies)
  125. Asbestos testing continues after boulder apartment fire (0 replies)
  126. [original articles] mortality of former crocidolite (blue asbestos) miners and millers at wittenoom (0 replies)
  127. [original articles: general thoracic] a phase ii trial of tetrathiomolybdate after surgery for malignant mesothelioma: final results (0 replies)
  128. [original articles: general thoracic] prevalence and pattern of lymph node metastasis in malignant pleural mesothelioma (0 replies)
  129. Libby, montana film receives emmy nomination (0 replies)
  130. Ca epa helps clean up homes after butte county fires (0 replies)
  131. Two ma theatre owners will pay asbestos fine (0 replies)
  132. American lung association issues new warning for people living near wildfires (0 replies)
  133. A phase ii trial of tetrathiomolybdate after surgery for malignant mesothelioma: final results. (0 replies)
  134. Prevalence and pattern of lymph node metastasis in malignant pleural mesothelioma. (0 replies)
  135. Environmental exposure to libby asbestos and mesotheliomas (0 replies)
  136. Primary yolk sac tumor of the omentum: a case report and review of the literature (0 replies)
  137. Lung cancer trial targets asbestos-related disease (0 replies)
  138. Nj environmental group targets chemical companies (0 replies)
  139. Epa announces public meeting to discuss asbestos risk assessment (0 replies)
  140. Long-term indwelling pleural catheter (pleurx) for malignant pleural effusion unsuitable for talc pleurodesis. (0 replies)
  141. Wyoming lot owners to finally remove asbestos (0 replies)
  142. Mass asbestos lawsuit dismissal in west virginia (0 replies)
  143. The comparative accuracy of different pleural biopsy techniques in the diagnosis of malignant mesothelioma. (0 replies)
  144. Orally ingested chrysotile asbestos affects rat lungs and pleura. (0 replies)
  145. Deceased’s estate files asbestos suit in illinois (0 replies)
  146. [thoracic oncology] pemetrexed plus gemcitabine as first-line chemotherapy for patients with peritoneal mesothelioma: final report of a phase ii trial (0 replies)
  147. [nanoparticles: structures, utilizations and health impacts.] (0 replies)
  148. Former railroad worker sues employer for toxin exposure (0 replies)
  149. Rlr investments says epa asbestos claims are untrue (0 replies)
  150. Lorain, ohio gets $3m for ford plant remediation (0 replies)
This is a "lo-fi" version of our main content. To view the full version with more information, formatting and images, please click here.
Invision Power Board © 2001-2008 Invision Power Services, Inc.